← All resources

EXPLORE A TOPIC

preclinical studies.

Research and resources to help you take a closer look.

The resource library

5 resources
BPC-1577 min read

Why Doesn’t Lack of Animal Toxicity Prove Human Safety for BPC-157?

Absence of observed toxicity in animal studies of BPC-157 does not establish its safety in humans. Differences in metabolism, physiology, and exposure duration between species, as well as the lack of robust human clinical data, mean that animal findings cannot be directly extrapolated to human safety. Current evidence highlights the need for caution and further research before drawing conclusions about human risk.

Selank6 min read

Elevated Plus Maze Endpoints in Selank Rat Studies: Research Interpretation

The elevated plus maze (EPM) is a validated behavioral assay for assessing anxiety-like behaviors in rodents. In Selank rat studies, EPM endpoints—such as time spent in open versus closed arms—serve as quantitative measures of anxiety, not direct clinical outcomes. This article reviews the experimental design, measured endpoints, and interpretation of EPM data in the context of Selank research, emphasizing methodological strengths, limitations, and the boundaries of preclinical inference.

GHK7 min read

What do GHK gene-expression studies reveal about nervous-system research, and what remains unproven?

GHK (glycyl-L-histidyl-L-lysine) gene-expression studies suggest this peptide modulates numerous genes relevant to nervous system health, including those involved in nerve outgrowth, antioxidant defense, DNA repair, and protein clearance. However, most evidence comes from in vitro, animal, and computational models, not controlled human trials. The translation of these findings to clinical outcomes remains unproven, and substantial limitations exist.